Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. The SELL prediction by Midas for Cymabay Therapeutics Inc performed very well with a performance of -36.21%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -0.727% | 2.783% | 28.954% | 84.155% |
| iShares Nasdaq 100 | 1.839% | 5.294% | 5.747% | 68.025% |
| iShares Nikkei 225® | -2.033% | -0.196% | -4.367% | 19.305% |
| iShares S&P 500 | 1.334% | 4.044% | 5.224% | 45.770% |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc